Oxford Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-5,569
Closed -$619K 1613
2019
Q4
$619K Sell
5,569
-19,986
-78% -$2.06M 0.02% 1132
2019
Q3
$2.54M Buy
25,555
+18,309
+253% +$1.82M 0.06% 411
2019
Q2
$718K Sell
7,246
-11,663
-62% -$1.11M 0.02% 1122
2019
Q1
$2.08M Buy
18,909
+16,325
+632% +$1.71M 0.05% 561
2018
Q4
$238K Sell
2,584
-10,657
-80% -$1.08M 0.01% 1483
2018
Q3
$1.46M Buy
+13,241
New +$1.38M 0.03% 833
2018
Q2
Sell
-18,213
Closed -$1.51M 2010
2018
Q1
$1.51M Buy
18,213
+3,530
+24% +$314K 0.03% 726
2017
Q4
$1.34M Sell
14,683
-31,317
-68% -$2.61M 0.03% 786
2017
Q3
$3.49M Sell
46,000
-12,096
-21% -$914K 0.07% 348
2017
Q2
$4.36M Buy
58,096
+21,579
+59% +$1.5M 0.09% 243
2017
Q1
$2.38M Buy
36,517
+28,687
+366% +$1.69M 0.06% 395
2016
Q4
$432K Buy
+7,830
New +$430K 0.02% 610
2016
Q1
Sell
-22,440
Closed -$1.06M 947
2015
Q4
$1.06M Buy
+22,440
New +$943K 0.03% 524

Other funds holding PRAH

Oxford Asset Management's PRAH Position: Q1 2020 in Review

Oxford Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 5,569 shares — an estimated $619K sold.

Oxford Asset Management first reported a position in PRAH in Q4 2015 and held it in 13 quarters. The position peaked at $4.36M in Q2 2017. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Oxford Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 5,569 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $619K.
  • Oxford Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 13 quarters.
  • Oxford Asset Management's PRA Health Sciences, Inc. position peaked at $4.36M in Q2 2017.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.